World's Best Scientists 2026 revealed!
Paola Cipriani

Paola Cipriani

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 57 3633 3350 147 139 282 11117

Paola Cipriani publications per year

The chart shows the history of publications by Paola Cipriani between 1951 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Paola Cipriani published across 75 years, from 1951 to 2025, averaging 4.4 papers a year. Output peaked at 25 publications in 2020. 20 of the 333 publications appeared in the last two years.

No. of publications
5 10 15 20 25
Bar chart. Horizontal axis: year, 1951 to 2025. Vertical axis: number of publications, 0 to 25. Peak 25 publications in 2020. 1951: 3 publications 1952: 0 publications 1953: 0 publications 1954: 0 publications 1955: 0 publications 1956: 0 publications 1957: 0 publications 1958: 0 publications 1959: 0 publications 1960: 0 publications 1961: 0 publications 1962: 0 publications 1963: 0 publications 1964: 0 publications 1965: 0 publications 1966: 0 publications 1967: 0 publications 1968: 2 publications 1969: 1 publication 1970: 0 publications 1971: 0 publications 1972: 1 publication 1973: 0 publications 1974: 0 publications 1975: 1 publication 1976: 0 publications 1977: 0 publications 1978: 0 publications 1979: 0 publications 1980: 0 publications 1981: 0 publications 1982: 0 publications 1983: 0 publications 1984: 2 publications 1985: 5 publications 1986: 1 publication 1987: 1 publication 1988: 0 publications 1989: 2 publications 1990: 0 publications 1991: 2 publications 1992: 2 publications 1993: 3 publications 1994: 1 publication 1995: 1 publication 1996: 2 publications 1997: 4 publications 1998: 6 publications 1999: 4 publications 2000: 0 publications 2001: 5 publications 2002: 6 publications 2003: 2 publications 2004: 5 publications 2005: 2 publications 2006: 7 publications 2007: 5 publications 2008: 9 publications 2009: 3 publications 2010: 3 publications 2011: 8 publications 2012: 3 publications 2013: 14 publications 2014: 14 publications 2015: 19 publications 2016: 23 publications 2017: 22 publications 2018: 14 publications 2019: 17 publications 2020: 25 publications 2021: 22 publications 2022: 24 publications 2023: 17 publications 2024: 10 publications 2025: 10 publications
1951 2025

333 publications in total across all disciplines

View publications per year as a table
Paola Cipriani: publications per year, 1951 to 2025
Year Publications
1951 3
1952 0
1953 0
1954 0
1955 0
1956 0
1957 0
1958 0
1959 0
1960 0
1961 0
1962 0
1963 0
1964 0
1965 0
1966 0
1967 0
1968 2
1969 1
1970 0
1971 0
1972 1
1973 0
1974 0
1975 1
1976 0
1977 0
1978 0
1979 0
1980 0
1981 0
1982 0
1983 0
1984 2
1985 5
1986 1
1987 1
1988 0
1989 2
1990 0
1991 2
1992 2
1993 3
1994 1
1995 1
1996 2
1997 4
1998 6
1999 4
2000 0
2001 5
2002 6
2003 2
2004 5
2005 2
2006 7
2007 5
2008 9
2009 3
2010 3
2011 8
2012 3
2013 14
2014 14
2015 19
2016 23
2017 22
2018 14
2019 17
2020 25
2021 22
2022 24
2023 17
2024 10
2025 10
Total 333
Download as CSV

Paola Cipriani publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Paola Cipriani sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 282–291 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 282 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115 282
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Paola Cipriani D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Paola Cipriani sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 56–57 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 57 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194 57
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Paola Cipriani is affiliated with the University of L'Aquila in Italy and has contributed extensively to the field of Medicine, with a particular focus on Rheumatology, Hematology, Immunology, Surgery, and Pathology and Forensic Medicine. Their research output includes a significant number of publications in these areas, reflecting a broad engagement with clinical and experimental medical sciences.

The primary fields of study for Cipriani encompass:

  • Medicine

More specifically, the subfields they have focused on include:

  • Rheumatology
  • Hematology
  • Immunology
  • Surgery
  • Pathology and Forensic Medicine

Cipriani's main research topics involve several autoimmune and inflammatory conditions and their treatment strategies, including:

  • Autoimmune and Inflammatory Disorders Research
  • Rheumatoid Arthritis Research and Therapies
  • Spondyloarthritis Studies and Treatments
  • Kawasaki Disease and Coronary Complications
  • Systemic Sclerosis and Related Diseases
  • Psoriasis: Treatment and Pathogenesis
  • Systemic Lupus Erythematosus Research

Among frequently publishing coauthors are:

  • Roberto Giacomelli
  • Piero Ruscitti
  • Onorina Berardicurti
  • Ilenia Di Cola
  • Luca Navarini

Paola Cipriani has contributed to several publication venues, with multiple works appearing in:

  • Annals of the Rheumatic Diseases
  • Clinical and Experimental Rheumatology
  • Autoimmunity Reviews
  • Frontiers in Medicine
  • Scientific Reports

A selection of recent papers coauthored by Cipriani includes:

  • "Beyond the joints, the extra-articular manifestations in rheumatoid arthritis," 2020, Autoimmunity Reviews
  • "Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm," 2020, Frontiers in Immunology
  • "The economic burden of fibromyalgia: A systematic literature review," 2022, Seminars in Arthritis and Rheumatism
  • "The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus," 2020, Autoimmunity Reviews
  • "Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations," 2020, Scientific Reports

Best Publications

  • Beyond the joints, the extra-articular manifestations in rheumatoid arthritis.

    Alessandro Conforti;Ilenia Di Cola;Viktoriya Pavlych;Piero Ruscitti

  • Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation?

    Alessandra Marrelli;Paola Cipriani;Vasiliki Liakouli;Francesco Carubbi

  • The role of IL-1β in the bone loss during rheumatic diseases.

    Piero Ruscitti;Paola Cipriani;Francesco Carubbi;Vasiliki Liakouli

  • Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry

    Fabiola Atzeni;Piercarlo Sarzi-Puttini;Costantino Botsios;Antonio Carletto

  • Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

    Francesco Carubbi;Paola Cipriani;Alessandra Marrelli;Paola Di Benedetto

  • Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.

    P. Cipriani;S. Guiducci;I. Miniati;M. Cinelli

  • Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis

    Roberto Giacomelli;Gabriele Valentini;Felice Salsano;Paola Cipriani

  • Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers

    Piero Ruscitti;Paola Cipriani;Francesco Masedu;Daniela Iacono

  • International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management

    Roberto Giacomelli;Antonella Afeltra;Alessia Alunno;Chiara Baldini

  • Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients

    P. Ruscitti;P. Cipriani;P. Di Benedetto;V. Liakouli

  • Iron availability influences aggregation, biofilm, adhesion and invasion of Pseudomonas aeruginosa and Burkholderia cenocepacia.

    F Berlutti;C Morea;A Battistoni;S Sarli

  • Methotrexate: an old new drug in autoimmune disease

    Paola Cipriani;Piero Ruscitti;Francesco Carubbi;Vasiliki Liakouli

  • Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.

    Roberto Giacomelli;Antonella Afeltra;Alessia Alunno;Elena Bartoloni-Bocci

  • The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis

    Mirko Manetti;Lidia Ibba-Manneschi;Vasiliki Liakouli;Serena Guiducci

  • The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist

    Paola Cipriani;Paola Di Benedetto;Piero Ruscitti;Daria Capece

  • Angiogenic cytokines and growth factors in systemic sclerosis

    Vasiliki Liakouli;Paola Cipriani;Alessandra Marrelli;Saverio Alvaro

  • Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors.

    Florenzo Iannone;Elisa Gremese;Fabiola Atzeni;Domenico Biasi

  • Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial

    Piero Ruscitti;Francesco Masedu;Saverio Alvaro;Paolo Airò

  • Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion

    R Perricone;C De Carolis;B Kröegler;E Greco

  • Tocilizumab for the treatment of adult-onset Still's disease: results from a case series.

    Paola Cipriani;Piero Ruscitti;Francesco Carubbi;Ilenia Pantano

  • Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study.

    Serena Colafrancesco;Roberta Priori;Guido Valesini;Lorenza Argolini

Frequent Co-Authors

Roberto Giacomelli
Roberto Giacomelli Campus Bio Medico University Hospital
Roberto Gerli
Roberto Gerli University of Perugia
Alessia Alunno
Alessia Alunno University of L'Aquila
Giovanni Cioni
Giovanni Cioni University of Pisa
Roberto Perricone
Roberto Perricone University of Rome Tor Vergata
Francesco Caso
Francesco Caso University of Naples Federico II
Fabiola Atzeni
Fabiola Atzeni University of Messina
Marco Matucci-Cerinic
Marco Matucci-Cerinic University of Florence
Riccardo Alessandro
Riccardo Alessandro University of Palermo
Carlo Perricone
Carlo Perricone University of Perugia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology often opens doors to various specialized healthcare roles, including advanced nursing positions. For those interested in combining clinical expertise with research, exploring top PMHNP programs can provide valuable insights into mental health, a crucial aspect of immunological disorders. Programs highlighted in top pmhnp programs are known for their excellent clinical placement rates, ensuring hands-on experience alongside theoretical knowledge.

Cost is a significant factor for many students pursuing further education. Identifying more affordable options without compromising quality is essential. The list of cheapest online pmhnp certificate programs offers a great starting point for those balancing budget and career advancement goals.

Career growth in fields tied to Immunology or nursing specialties often comes with varying salary potentials. Understanding the dnp salary by state can help professionals make informed decisions about job locations and negotiate better compensation packages.

For nurses seeking to expand their expertise, transitioning from a Family Nurse Practitioner (FNP) role to an acute care setting is a common pathway. Guidance on how to make this shift effectively can be found in resources about fnp to acute care np, which provides practical steps and certification requirements.

Best Scientists Citing Paola Cipriani

Trending Scientists

Recently Published Articles